Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.6K Sell
18,606
-91,002
-83% -$368K ﹤0.01% 7307
2026
Q1
$466K Buy
109,608
+107,458
+4,998% +$480K ﹤0.01% 6129
2025
Q4
$10.3K Buy
2,150
+1,907
+785% +$9.35K ﹤0.01% 8229
2025
Q3
$1.09K Sell
243
-704
-74% -$2.36K ﹤0.01% 9439
2025
Q2
$2.47K Sell
947
-17,499
-95% -$59.2K ﹤0.01% 9460
2025
Q1
$72.1K Buy
18,446
+18,418
+65,779% +$77.8K ﹤0.01% 7307
2024
Q4
$112 Sell
28
-1,355
-98% -$7.77K ﹤0.01% 9638
2024
Q3
$9.2K Buy
+1,383
New +$5.62K ﹤0.01% 7796
2023
Q4
Sell
-130
Closed -$770 9588
2023
Q3
$770 Buy
+130
New +$953 ﹤0.01% 8289

Other funds holding IONR

UBS Group's IONR Position: Q2 2026 in Review

UBS Group reduced its Ioneer (IONR) stake by 83% in Q2 2026, selling an estimated $368K and leaving 18,606 shares worth $80.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7307.

UBS Group first reported a position in IONR in Q3 2023 and has held it in 9 quarters since. The position peaked at $466K in Q1 2026. 33 funds tracked by Wall St. Rank hold IONR as of Q2 2026.

  • UBS Group held 18,606 shares of Ioneer worth $80.6K as of Q2 2026.
  • UBS Group sold 91,002 Ioneer shares in Q2 2026, an estimated $368K.
  • Ioneer made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7307 holding.
  • UBS Group first reported a position in Ioneer in Q3 2023 and has held it in 9 quarters since.
  • UBS Group's Ioneer position peaked at $466K in Q1 2026.
  • 33 funds tracked by Wall St. Rank held Ioneer as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.